PPAR-γ agonists decrease hyperhomcysteinemia and cardiac dysfunction: New hope for ailing diabetic hearts?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 1, 2006, Pages

  Rocic, Petra ^a   Rezk, Bashir ^a   Lucchesi, Pamela A ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HOMOCYSTEINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE;

AMINO ACID BLOOD LEVEL; BLOOD PRESSURE; CELLULAR DISTRIBUTION; DRUG EFFECT; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EXCITATION CONTRACTION COUPLING; HEART CONTRACTION; HEART DISEASE; HUMAN; HYPERHOMOCYSTEINEMIA; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARDIOTONIC AGENTS; DIABETES COMPLICATIONS; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MICE; PPAR GAMMA; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745758096     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00277.2006     Document Type: Editorial

References (24)

1. Au-Yeung KKW, Woo CWH, Sung FL, Yip JCW, Siow YL, and OK. Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ Res 94: 28-36, 2004.
2. Becker JS, Adler A, Schneeberger A, Huang H, Wang Z, Walsh E, Koller A, and Hintze TH. Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation 111: 2112-2118, 2005.
3. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83: 59-115, 2003.
4. Calnek DS, Mazzella L, Roser S, Roman J, and Hart CM. Peroxisome proliferator-activated receptor-γ ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 23: 52-57, 2003.
5. Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, and Severson DL. Treatment of type 2 diabetic db/db mice with a novel PPAR-γ agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 286: E449 -E455, 2004.
6. Carroll JF and Tyagi SC. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens 18: 692- 698, 2005.
7. Cesari M, Zanchetta M, Burlina A, Pedon L, Maiolino G, Sticchi D, Pessina AC, and Rossi GP. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 25: 115-121, 2005.
8. Chen K, Li D, Zhang X, Hermonat PL, and Mehta JL. Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-γ ligand pioglitazone. J Cardiovasc Pharmacol 44: 682-687, 2004.
9. Diep QN, Amiri F, Benkirane K, Paradis P, and Schiffrin EL. Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. Can J Physiol Pharmacol 82: 976-985, 2004.
10. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, and Hart CM. Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288: C899-C905, 2005.
11. Iglarz M, Touyz RM, Viel EC, Paradis P, Amiri F, Diep QN, and Schiffrin EL. Peroxisome proliferator-activated receptor-α and receptor-γ activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension. Hypertension 42: 737-743, 2003.
12. Kennedy RH, Owings R, Shekhawat N, and Joseph J. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Circ Physiol 287: H812-H817, 2004.
13. Lehrke M and Lazar MA. The many faces of PPAR-γ. Cell 123: 993-999, 2005.
14. Murthy SN, Obregon DF, Chattergoon NN, Fonseca NA, Mondal D, Dunne JB, Diez JG, Jeter JR Jr, Kadowitz PJ, Agrawal KC, McNamara DB, and Fonseca VA. Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet. Metabolism 54: 645-652, 2005.
15. Nemoto S, Razeghi P, Ishiyama M, De Freitas G, Taegtmeyer H, and Carabello BA. PPAR-γ agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation. Am J Physiol Heart Circ Physiol 288: H77-H82, 2005.
16. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-82, 1998.
17. Rodriguez WE, Joshua IG, Falcone JC, and Tyagi SC. Pioglitazone prevents cardiac remodeling in high-fat high-calorie induced Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 291: H81-H87, 2006.
18. Rosen ED and Spiegelman BM. PPAR-γ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276: 37731-37734, 2001.
19. Rudy A, Kowalska I, Straczkowski M, and Kinalska I. Homocysteine concentrations and vascular complications in patients with type 2 diabetes. Diabetes Metab 31: 112-117, 2005.
20. Schiffrin EL. Peroxisome proliferator-activated receptors and cardiovascular remodeling. Am J Physiol Heart Circ Physiol 288: H1037-H1043, 2005.
21. Tyagi N, Moshal KS, Lominadze D, Ovechkin AV, and Tyagi SC. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model. Can J Physiol Pharmacol 83: 583-594, 2005.
22. Tyagi SC, Rodriguez W, Patel AM, Roberts AM, Falcone JC, Passmore JC, Fleming JT, and Joshua IG. Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling. J Cardiovasc Pharmacol Ther 10: 1-10, 2005.
23. Walker E, Black J, Parris C, Bryda EC, Cansino S, Hunt L, Chappell J, Wehner P, Studeny M, and Wright GL. Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat. Ann Clin Lab Sci 34: 175-180, 2004.
24. Zhu P, Lu L, Xu Y, and Schwartz GG. Troglitazone improves recovery of left ventricular function after regional ischemia in pigs. Circulation 101: 1165-1171, 2000.